Have you noticed a change in memory? We are recruiting for a research study called EVOKE. The purpose of the 3-year study is to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer’s disease. This will be done by comparing semaglutide against placebo on the effect on cognition and daily functioning. Semaglutide is already used to treat people with type 2 diabetes.

This will be investigated further in this study by:
• Comparing tests taken at the start of the study with those taken at end of the study
• Collecting information about your health, cognition, ability to perform daily activities and general wellbeing
• Different blood samples and measurements are taken during the study to monitor your health.

This study is taking place in Dundee, Edinburgh and Aberdeen.

If you are interested in taking part in the study, please complete the questions below. If you would like to speak with the SHARE Team, please call 01382 383471.